Effect of Co-Morbidities on Mortality from COVID-19 in Mexico: an Ecological Study-Reference-Cited by-同舟云学术

Effect of Co-Morbidities on Mortality from COVID-19 in Mexico: an Ecological Study

Published:2021-03-30 Issue:1 Volume:14 Page:07-13
ISSN:2456-2610
Container-title:Biomedical and Pharmacology Journal
language:en
Short-container-title:Biomed. Pharmacol. J.

Author:

Padilla-Raygoza Nicolás¹^ORCID,Vega-Jimenez Oscar Ulises¹^ORCID,Juárez Andrea García¹^ORCID,Gallardo-Luna María de Jesús²^ORCID,Navarro-Olivos Efraín²^ORCID,León-Verdin Ma Guadalupe²^ORCID,Magos-Vázquez Francisco J.²^ORCID,Díaz-Martínez Daniel Alberto²^ORCID

Affiliation:

1. School of Medicine, University of Celaya, México 38080.

2. Secretary of Health from Guanajuato State, México, 36000.

Abstract

With the emergence of a SARS-CoV-2 infection pandemic in China and its spread to other countries, mortality was shown to be high and to a greater extent if there were underlying pathologies. It is said {or an ecological analytical cross-sectional study, of the open records of confirmed and discarded cases for COVID-19 of the General Directorate of Epidemiology of the Secretary of Health of Mexico. A specific mortality of 9.79% is reported; being higher in men between the ages of 20 to 59 and over 60 years. Mortality rates from underlying diseases were higher than those reported in the USA in early May 2020. Asthma was found to be a protective factor for COVID-19 mortality. It is concluded that mortality was higher in the presence of comorbidities.

Publisher

Oriental Scientific Publishing Company

Subject

Pharmacology

Reference33 articles.

1. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020;92(4):401-402. Doi: https://doi.org/10.1002/jmv.25678.

2. CrossRef

3. Hui DS, Azhar EI, Madani TA, Ntoumi F, Kock R, Dar O, et al.The continuing 2019-nCoV epidemic threatof novel coronaviruses to global health – the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020; 91: 264-66 Doi: https://doi.org/10.1016/j.ijid.2020.01.009

4. CrossRef

5. Huang C, Wang Y, Li X, Ren L, Zhao J, Yi Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506 Doi: https://doi.org/10.1016/S0140-6736(20)30183-5

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Introductory Chapter: Multisystem Inflammation Syndrome;Multisystem Inflammatory Syndrome - Natural History;2024-01-31

2. Pre-Pathogenic Period of Multisystemic Inflammatory Syndrome: Ecological Triad;Multisystem Inflammatory Syndrome - Natural History;2023-09-20